260 related articles for article (PubMed ID: 3496271)
21. Comparison of phorbol myristate acetate and phytohaemagglutinin as stimulators of in vitro T lymphocyte colony formation of human peripheral blood lymphocytes. I. Surface markers of colony cells.
Suzawa T; Hyodo S; Kishi T; Kashiwa H; Karakawa T; Kittaka E; Sakano T; Usui T
Immunology; 1984 Nov; 53(3):499-505. PubMed ID: 6333386
[TBL] [Abstract][Full Text] [Related]
22. Interactions of human T cell subsets during the induction of cytotoxic T lymphocytes: the role of interleukins.
Solbach W; Barth S; Röllinghoff M; Wagner H
Clin Exp Immunol; 1982 Jul; 49(1):167-75. PubMed ID: 6215193
[TBL] [Abstract][Full Text] [Related]
23. T cell growth factor-enhanced PHA response of human thymus cells: requirement for T3+ cells.
Hayward AR; Kurnick JT; Clarke DR
J Immunol; 1981 Nov; 127(5):2079-82. PubMed ID: 6975307
[TBL] [Abstract][Full Text] [Related]
24. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
Schwab R; Crow MK; Russo C; Weksler ME
J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
[TBL] [Abstract][Full Text] [Related]
25. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
[TBL] [Abstract][Full Text] [Related]
26. The role of interleukin-2 in T colony formation by human pre-T cells (pTCFC).
Rey A; Klein B; Ilnicki C; Jourdan M; Serrou B
Clin Exp Immunol; 1984 Oct; 58(1):154-60. PubMed ID: 6332691
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.
Miyawaki T; Yachie A; Ohzeki S; Nagaoki T; Taniguchi N
J Immunol; 1983 Jun; 130(6):2737-42. PubMed ID: 6406595
[TBL] [Abstract][Full Text] [Related]
28. Concanavalin A triggers T lymphocytes by directly interacting with their receptors for activation.
Palacios R
J Immunol; 1982 Jan; 128(1):337-42. PubMed ID: 6459373
[TBL] [Abstract][Full Text] [Related]
29. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
Redelman D
Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of HLA-DR antigen expression in phytohemagglutinin-activated T cells in man. Requirement of T cell recognition of self HLA-DR antigen expressed on the surface of monocytes.
Moriya N; Sanjoh K; Yokoyama S; Hayashi T
J Immunol; 1987 Nov; 139(10):3281-6. PubMed ID: 3500214
[TBL] [Abstract][Full Text] [Related]
31. The effect of drugs used in anticoagulation therapy on T lymphocyte activation in vitro. I. Heparin inhibits activation by soluble antigen or allogeneic cells but not by phytohaemagglutinin.
Bruserud O; Lundin K
J Clin Lab Immunol; 1987 Jul; 23(3):117-21. PubMed ID: 3499516
[TBL] [Abstract][Full Text] [Related]
32. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.
Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756
[TBL] [Abstract][Full Text] [Related]
33. IL-4 expression in human T cells is selectively inhibited by IL-1 alpha and IL-1 beta.
Sandborg CI; Imfeld KL; Zaldivar F; Wang Z; Buckingham BA; Berman MA
J Immunol; 1995 Dec; 155(11):5206-12. PubMed ID: 7594531
[TBL] [Abstract][Full Text] [Related]
34. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody.
Mannie MD; Morrison-Plummer J; McConnell TJ
J Immunol; 1993 Dec; 151(12):7293-306. PubMed ID: 7505025
[TBL] [Abstract][Full Text] [Related]
35. Novel in vitro effects of bucillamine: inhibitory effects on proinflammatory cytokine production and transendothelial migration of T cells.
Munakata Y; Iwata S; Dobers J; Ishii T; Nori M; Tanaka H; Morimoto C
Arthritis Rheum; 2000 Jul; 43(7):1616-23. PubMed ID: 10902767
[TBL] [Abstract][Full Text] [Related]
36. Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling.
Ranjan D; Chen C; Johnston TD; Jeon H; Nagabhushan M
J Surg Res; 2004 Oct; 121(2):171-7. PubMed ID: 15501456
[TBL] [Abstract][Full Text] [Related]
37. [Studies on the responsiveness of alveolar T cells to proliferative stimuli and on surface antigens].
Yamaguchi E
Hokkaido Igaku Zasshi; 1993 Mar; 68(2):224-36. PubMed ID: 8509065
[TBL] [Abstract][Full Text] [Related]
38. Immunologic effects of interleukin 2 in primary immunodeficiency diseases.
Flomenberg N; Welte K; Mertelsmann R; Kernan N; Ciobanu N; Venuta S; Feldman S; Kruger G; Kirkpatrick D; Dupont B; O'Reilly R
J Immunol; 1983 Jun; 130(6):2644-50. PubMed ID: 6222111
[TBL] [Abstract][Full Text] [Related]
39. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
[TBL] [Abstract][Full Text] [Related]
40. High-level IL-10 production by monoclonal antibody-stimulated human T cells.
Schwarz M; Majdic O; Knapp W; Holter W
Immunology; 1995 Nov; 86(3):364-71. PubMed ID: 8550072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
